Edition:
United States

Profile: Astellas Pharma Inc (4503.T)

4503.T on Tokyo Stock Exchange

1,554JPY
2 Dec 2016
Change (% chg)

¥-8 (-0.51%)
Prev Close
¥1,562
Open
¥1,552
Day's High
¥1,566
Day's Low
¥1,546
Volume
7,799,000
Avg. Vol
7,713,845
52-wk High
¥1,798
52-wk Low
¥1,358

Astellas Pharma Inc. is a Japan-based company mainly engaged in the pharmaceutical business. The Company is involved in the manufacture and sale of pharmaceutical products in Japan, the United States, Europe, China, Korea and Taiwan, through its subsidiaries. Its main products include immunosuppressive drug Prograf, overactive bladder agent Vesicare, Protopic ointment for atopic dermatitis, Harnal for prostatic and urethral smooth muscle, and antimycotic agent Funguard, among others. It also provides pharmaceutical products for gastritis, osteoporosis, hypertension, schizophrenia, rheumatoid arthritis, atopic dermatitis and other diseases. The Company also engages in the research and development of ophthalmology pharmaceuticals through its subsidiaries.

Company Address

Astellas Pharma Inc

Astellas Pharma Inc. Headquarter
2-5-1, Nihonbashihon-cho
CHUO-KU   TKY   103-8411
P: +813.32443000

Company Web Links